Connection

TAO SHEN to Carcinoma, Basal Cell

This is a "connection" page, showing publications TAO SHEN has written about Carcinoma, Basal Cell.
Connection Strength

0.219
  1. Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. Int J Med Sci. 2025; 22(10):2488-2501.
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.